MarketCap
Facebook
X
Telegram
Country |
 USA |
IPO year |
- |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
2.59 M |
Market Cap[1] |
$ 19.4 M |
EBITDA (LTM) |
$ -11.3 M |
P/E (LTM) |
- |
P/S (LTM) |
147.99416 |
EPS (LTM) |
-5.35 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Waters Corporation
WAT
|
$ 476.29 | -0.09 % | $ 28.4 B | NYSE,SPB | USA |
 |
Exagen
XGN
|
$ 5.26 | -25.92 % | $ 113 M | Nasdaq Global Market | USA |
 |
Celcuity
CELC
|
$ 67.13 | -4.11 % | $ 3.14 B | Nasdaq Global Select Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 370.89 | -0.25 % | $ 30.9 B | NYSE,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 101.65 | 0.63 % | $ 6.86 B | Nasdaq Global Select Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Medpace Holdings
MEDP
|
$ 664.97 | -1.18 % | $ 19.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Charles River Laboratories International
CRL
|
$ 346.21 | -2.02 % | $ 17.2 B | NYSE,SPB | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 750.2 | -0.69 % | $ 36.1 B | NYSE,SPB |  Schweiz |
 |
Danaher Corporation
DHR
|
$ 236.19 | 0.46 % | $ 168 B | NYSE,SPB | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 30.39 | -1.32 % | $ 28.8 B | NYSE |  Niderland |
 |
RadNet
RDNT
|
$ 77.91 | -0.6 % | $ 5.86 B | Nasdaq Global Select Market | USA |
 |
Senseonics Holdings
SENS
|
$ 10.05 | 2.55 % | $ 419 M | NYSE American | USA |
 |
Neuronetics
STIM
|
$ 2.01 | -7.8 % | $ 133 M | Nasdaq Global Select Market | USA |
 |
T2 Biosystems
TTOO
|
- | -39.35 % | $ 313 K | Nasdaq Global Select Market | USA |
 |
Thermo Fisher Scientific
TMO
|
$ 719.09 | -0.35 % | $ 271 B | NYSE,SPB | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Guardant Health
GH
|
$ 155.43 | -2.12 % | $ 19.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Brainsway Ltd.
BWAY
|
$ 10.63 | -8.68 % | $ 361 M | Nasdaq Global Select Market |  Israel |
 |
VolitionRx Limited
VNRX
|
$ 0.19 | -6.2 % | $ 23.9 M | NYSE American |  Singapore |
 |
Natera
NTRA
|
$ 311.81 | -1.92 % | $ 42.6 B | Nasdaq Global Select Market,SPB | USA |
 |
IQVIA Holdings
IQV
|
$ 275.46 | -1.21 % | $ 47.4 B | NYSE,SPB | USA |
 |
Agilent Technologies
A
|
$ 178.84 | -0.74 % | $ 50.8 B | NYSE,SPB | USA |
 |
Quotient Limited
QTNT
|
- | -11.32 % | $ 1.1 M | Nasdaq Global Select Market | Schweiz |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Surmodics
SRDX
|
- | - | $ 608 M | Nasdaq Global Select Market,SPB | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
 |
Syneos Health
SYNH
|
- | - | $ 4.46 B | Nasdaq Global Select Market,SPB | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Renalytix AI plc
RNLX
|
- | 5.66 % | $ 22.7 M | Nasdaq Global Market |  Britain |
 |
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | USA |
 |
Meridian Bioscience
VIVO
|
- | - | $ 1.49 B | Nasdaq Global Select Market | USA |
 |
DexCom
DXCM
|
$ 79.92 | -1.42 % | $ 31.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 258.38 | -0.5 % | $ 28.7 B | NYSE,SPB | USA |
 |
Castle Biosciences
CSTL
|
$ 34.41 | 0.07 % | $ 997 M | Nasdaq Global Market,SPB | USA |
 |
IDEXX Laboratories
IDXX
|
$ 696.77 | -1.4 % | $ 56 B | Nasdaq Global Select Market,SPB | USA |
 |
Illumina
ILMN
|
$ 214.84 | -2.69 % | $ 33.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Anixa Biosciences
ANIX
|
$ 3.05 | -3.48 % | $ 99 K | Nasdaq Capital Market | USA |
|
Biodesix
BDSX
|
$ 10.04 | -2.95 % | $ 75.8 M | Nasdaq Global Market | USA |
 |
BioNano Genomics
BNGO
|
$ 1.25 | 7.66 % | $ 6.81 M | Nasdaq Capital Market,SPB | USA |
 |
Bioventus
BVS
|
$ 11.18 | 1.5 % | $ 745 M | Nasdaq Global Select Market | USA |
 |
Fulgent Genetics
FLGT
|
$ 25.83 | -1.22 % | $ 795 M | Nasdaq Global Market | USA |
 |
CareDx, Inc
CDNA
|
$ 80.78 | -4.31 % | $ 4.3 B | Nasdaq Global Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | Britain |
 |
Biomerica
BMRA
|
$ 1.48 | -4.52 % | $ 4.31 M | Nasdaq Capital Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.